A Study of GANFORT UD in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) in a Medical Setting
Latest Information Update: 09 May 2019
Price :
$35 *
At a glance
- Drugs Bimatoprost/timolol (Primary)
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Therapeutic Use
- Sponsors Allergan
- 06 Apr 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov
- 23 Nov 2014 Planned End Date changed from 1 Apr 2015 to 1 Nov 2014 as reported by ClinicalTrials.gov
- 23 Nov 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov